Show simple item record

dc.contributor.authorHouse, A
dc.contributor.authorBryant, L
dc.contributor.authorRussell, AM
dc.contributor.authorWright-Hughes, A
dc.contributor.authorGraham, L
dc.contributor.authorWalwyn, R
dc.contributor.authorWright, JM
dc.contributor.authorHulme, C
dc.contributor.authorO'Dwyer, JL
dc.contributor.authorLatchford, G
dc.contributor.authorStansfield, A
dc.contributor.authorAjjan, R
dc.contributor.authorFarrin, A
dc.date.accessioned2022-07-21T10:54:55Z
dc.date.issued2018-03-25
dc.date.updated2022-07-21T10:14:31Z
dc.description.abstractAIMS: To undertake a feasibility randomized controlled trial of supported self-management vs treatment as usual in a population of adults with obesity, Type 2 diabetes and an intellectual disability. METHODS: We conducted an individually randomized feasibility trial. Participants were adults aged >18 years with a mild or moderate intellectual disability, living in the community with Type 2 diabetes, on any therapy other than insulin. Participants had mental capacity to consent to research and the intervention. Inclusion criteria included HbA1c > 48 mmol/mol (6.5%), BMI >25 kg/m2 , or self-reported physical activity below national guideline levels. The experimental intervention was standardized supported self-management delivered by diabetes specialist nurses plus treatment as usual, compared with treatment as usual alone. Feasibility outcomes included: recruitment and retention; intervention acceptability and feasibility; data collection and completeness for physiological state and values for candidate primary outcomes (HbA1c and BMI). RESULTS: A total of 82 participants (89% of those contacted and eligible) were randomized. All supported self-management sessions were completed by 35/41 participants (85%); only four completed no sessions. Data on the follow-up candidate primary outcomes HbA1c and BMI were obtained for 75/82 (91%) and 77/82 participants (94%), respectively. The mean baseline HbA1c was 56±16.5 mmol/mol (7.3±1.5%) and the mean BMI was 34±7.6 kg/m2 . CONCLUSIONS: Adherence to supported self-management and willingness to have blood taken for outcome measurement was good. A definitive randomized controlled trial is feasible in this population.en_GB
dc.description.sponsorshipNational Institute for Health Research Health Technology Assessment programmeen_GB
dc.format.extent776-788
dc.format.mediumPrint-Electronic
dc.identifier.citationVol. 35 (6), pp. 776-788en_GB
dc.identifier.doihttps://doi.org/10.1111/dme.13626
dc.identifier.grantnumber10/102/03en_GB
dc.identifier.urihttp://hdl.handle.net/10871/130321
dc.identifierORCID: 0000-0003-2077-0419 (Hulme, C)
dc.language.isoenen_GB
dc.publisherWiley / Diabetes UKen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/29575241en_GB
dc.rights© 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.en_GB
dc.titleRandomized controlled feasibility trial of supported self-management in adults with Type 2 diabetes mellitus and an intellectual disability: OK Diabetesen_GB
dc.typeArticleen_GB
dc.date.available2022-07-21T10:54:55Z
dc.identifier.issn0742-3071
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available from Wiley / Diabetes UK via the DOI in this record. en_GB
dc.identifier.eissn1464-5491
dc.identifier.journalDiabetic Medicineen_GB
dc.relation.ispartofDiabet Med, 35(6)
dc.rights.urihttp://creativecommons.org/licenses/by-nc/4.0/en_GB
dcterms.dateAccepted2018-03-13
dc.rights.licenseCC BY-NC
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2018-03-13
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2022-07-21T10:47:57Z
refterms.versionFCDVoR
refterms.dateFOA2022-07-21T10:55:01Z
refterms.panelAen_GB
refterms.depositExceptionpublishedGoldOA
refterms.dateFirstOnline2018-03-25


Files in this item

This item appears in the following Collection(s)

Show simple item record

© 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK.

This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Except where otherwise noted, this item's licence is described as © 2018 The Authors. Diabetic Medicine published by John Wiley & Sons Ltd on behalf of Diabetes UK. This is an open access article under the terms of the Creative Commons Attribution-NonCommercial License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.